Literature DB >> 9513906

Mechanisms contributing to muscle-wasting in acute uremia: activation of amino acid catabolism.

S R Price1, D Reaich, A C Marinovic, B K England, J L Bailey, R Caban, W E Mitch, B J Maroni.   

Abstract

Acute uremia (ARF) causes metabolic defects in glucose and protein metabolism that contribute to muscle wasting. To examine whether there are also defects in the metabolism of essential amino acids in ARF, we measured the activity of the rate-limiting enzyme for branched-chain amino acid catabolism, branched-chain ketoacid dehydrogenase (BCKAD), in rat muscles. Because chronic acidosis activates muscle BCKAD, we also evaluated the influence of acidosis by studying ARF rats given either NaCl (ARF-NaCl) or NaHCO3 (ARF-HCO3) to prevent acidosis, and sham-operated, control rats given NaHCO3. ARF-NaCl rats became progressively acidemic (serum [HCO3] = 21.3 +/- 0.7 mM within 18 h and 14.7 +/- 0.8 mM after 44 h; mean +/- SEM), but this was corrected with NaHCO3. Plasma valine was low in ARF-NaCl and ARF-HCO3 rats. Plasma isoleucine, but not leucine, was low in ARF-NaCl rats, and isoleucine tended to be lower in ARF-HCO3 rats. Basal BCKAD activity (a measure of active BCKAD in muscle) was increased more than 17-fold (P < 0.01) in ARF-NaCl rat muscles, and this response was partially suppressed by NaHCO3. Maximal BCKAD activity (an estimate of BCKAD content), subunit mRNA levels, and BCKAD protein content were not different in ARF and control rat muscles. Thus, ARF increases branched-chain amino acid catabolism by activating BCKAD by a mechanism that includes acidosis. Moreover, in a muscle-wasting condition such as ARF, there is a coordinated increase in protein and essential amino acid catabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513906     DOI: 10.1681/ASN.V93439

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  5 in total

Review 1.  Physical inactivity: a risk factor and target for intervention in renal care.

Authors:  Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

2.  Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration.

Authors:  Foteini Mourkioti; Paschalis Kratsios; Tom Luedde; Yao-Hua Song; Patrick Delafontaine; Raffaella Adami; Valeria Parente; Roberto Bottinelli; Manolis Pasparakis; Nadia Rosenthal
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

Review 3.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

4.  Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities.

Authors:  Enrico Fiaccadori; Giuseppe Regolisti; Aderville Cabassi
Journal:  NDT Plus       Date:  2009-02-11

5.  Regular exercise and branched-chain amino acids prevent ischemic acute kidney injury-related muscle wasting in mice.

Authors:  Soichiro Nagata; Akihiko Kato; Shinsuke Isobe; Tomoyuki Fujikura; Naro Ohashi; Hiroaki Miyajima; Hideo Yasuda
Journal:  Physiol Rep       Date:  2020-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.